Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bicycle Therapeutics (BCYC) Shares Issued (2019 - 2025)

Bicycle Therapeutics' Shares Issued history spans 7 years, with the latest figure at $33000.0 for Q4 2025.

  • For Q4 2025, Shares Issued fell 99.99% year-over-year to $33000.0; the TTM value through Dec 2025 reached $37000.0, down 99.99%, while the annual FY2025 figure was $37000.0, 99.99% down from the prior year.
  • Shares Issued reached $33000.0 in Q4 2025 per BCYC's latest filing, up from $1000.0 in the prior quarter.
  • In the past five years, Shares Issued ranged from a high of $536.8 million in Q4 2024 to a low of -$67.8 million in Q3 2021.
  • Average Shares Issued over 5 years is $43.6 million, with a median of $681000.0 recorded in 2022.
  • Peak YoY movement for Shares Issued: plummeted 678340.0% in 2021, then surged 5368340.0% in 2024.
  • A 5-year view of Shares Issued shows it stood at $286.1 million in 2021, then tumbled by 98.29% to $4.9 million in 2022, then tumbled by 99.8% to $10000.0 in 2023, then soared by 5368340.0% to $536.8 million in 2024, then crashed by 99.99% to $33000.0 in 2025.
  • Per Business Quant, the three most recent readings for BCYC's Shares Issued are $33000.0 (Q4 2025), $1000.0 (Q3 2025), and $1000.0 (Q2 2025).